治疗后低血糖的预测因素:一个多中心的回顾性队列研究
Mansour Bahardoust1, Ali Ranjbarpazuki2, Mohammadsadra Shamohammadi3
1Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Endocrinology, diabetes & metabolism
|November 9, 2025
概括
腹后低血糖症 (PBH) 影响超过35%的患者在18个月内. 女性性别,低教育和维生素缺乏增加了风险,而2型糖尿病提供了保护.
科学领域:
- 内分泌学 在内分泌学.
- 代谢手术 代谢手术
- 临床营养学 临床营养学
背景情况:
- 减肥后低血糖症 (PBH) 是减肥手术后的一种严重并发症.
- PBH通常在Roux-en-Y胃绕道 (RYGB) 和袖子胃切除术 (SG) 等手术后1-3年表现出来.
研究的目的:
- 为了确定PBH的预测因子,在一个大型的,多中心队列的减肥手术患者.
- 分析与PBH发展相关的社会人口结构,代谢和营养因素.
主要方法:
- 追溯分析952名肥胖患者 (BMI ≥35 kg/m2) 接受RYGB或SG.
- 通过惠普尔三位一体定义的PBH:生化低血糖 (<3.0 mmol/L) 与症状.
- 多变量逻辑回归用于在手术后12,15和18个月评估风险因素.
主要成果:
- 在18个月内,PBH累积发病率达到35.4%.
- 与女性性别,高中教育,维生素B1/B12缺乏和RYGB相关的PBH风险增加.
- 保护因素包括2型糖尿病,更高的基线HbA1c和更长的糖尿病持续时间.
结论:
- PBH是在减肥手术后的一个常见而复杂的并发症.
- 代谢,社会人口和营养因素对于评估PBH风险至关重要.
- 需要进一步的研究和有针对性的干预措施来缓解PBH.
相关概念视频
Hypoglycemia and Glucagon
787
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
787
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
230
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230
Oral Hypoglycemic Agents: Biguanides and Glitazones
568
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
568
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
SBAR II: Application of SBAR
5.6K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.6K


